Publications

Title

Author

Year

Systematic analysis of funding awarded to institutions in the United Kingdom for infectious disease research, 1997-2010.

Head, MG; FITCHETT, JR; MOORE, DA; Atun, R;

2015

JRSM open, (2015).6 3 10.1177/2054270415577056.

Reply to "adequate design of pharmacokinetic-pharmacodynamic studies will help optimize tuberculosis treatment for the future".

Requena-Méndez, A; Davies, G; MOORE, DA J;

2015

Antimicrobial agents and chemotherapy, (2015).59 4 10.1128/AAC.05182-14.

Effective anti-tuberculosis therapy correlates with plasma small RNA.

Honeyborne, I; Lipman, MC; ECKOLD, C; Evangelopoulos, D; Gillespie, SH; Pym, A; McHugh, TD;

2015

The European respiratory journal, (2015).45 6 10.1183/09031936.00221214.

Large-scale whole genome sequencing of M. tuberculosis provides insights into transmission in a high prevalence area.

Guerra-Assunção, JA; CRAMPIN, AC; HOUBEN, RM G J; MZEMBE, T; Mallard, K; COLL, F; KHAN, P; Banda, L; Chiwaya, A; Pereira, RP A; MCNERNEY, R; FINE, PE M; Parkhill, J; CLARK, TG; GLYNN, JR;

2015

eLife, (2015).4 4 10.7554/eLife.05166.

To improve our tuberculosis burden estimates we need to learn from each other.

HOUBEN, RM G J; WHITE, RG;

2015

The international journal of tuberculosis and lung disease, (2015).19 3 10.5588/ijtld.15.0037.

Regarding the effect of cured tuberculosis disease on longevity.

LALLI, M; HOUBEN, R; CHURCHYARD, G; WHITE, RG;

2015

The international journal of tuberculosis and lung disease, (2015).19 3 10.5588/ijtld.14.0852.

Multidrug resistant tuberculosis.

Millard, J; Ugarte-Gil, C; MOORE, DA J;

2015

BMJ (Clinical research ed), (2015).350 feb26 10.1136/bmj.h882.

Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus.

Ronacher, K; Joosten, SA; Van Crevel, R; DOCKRELL, HM; Walzl, G; Ottenhoff, TH M;

2015

Immunological reviews, (2015).264 1 10.1111/imr.12257.

The human immune response to tuberculosis and its treatment: a view from the blood.

CLIFF, JM; Kaufmann, SH E; McShane, H; Van Helden, P; O'Garra, A;

2015

Immunological reviews, (2015).264 1 10.1111/imr.12269.

Modelling the HIV epidemic among MSM in the United Kingdom: quantifying the contributions to HIV transmission to better inform prevention initiatives.

Punyacharoensin, N; EDMUNDS, WJ; De Angelis, D; Delpech, V; Hart, G; Elford, J; Brown, A; Gill, N; WHITE, RG;

2015

AIDS (London, England), (2015).29 3 10.1097/QAD.0000000000000525.